The headline multiple is 239x trailing earnings and 79x revenue. On those numbers, the stock is expensive by any historical standard for any business in any sector.
The counterargument starts with FCF, not earnings. Trailing FCF margin is approaching 47%, which means the earnings number understates the cash the business is generating. On a price-to-FCF basis the multiple compresses to roughly 170x, still elevated but more meaningful as a starting point.
The more useful exercise is a forward look. If Palantir maintains 30% annual revenue growth through 2027, revenue reaches approximately $7.6 billion. If operating margins continue to expand toward 40%, and there is a credible path given the fixed-cost leverage already demonstrated, operating income approaches $3 billion. Apply a 50x forward earnings multiple, which is already generous, and the implied market cap is $150 billion. The current market cap is $355 billion.
That math does not work unless growth sustains above 40%, margins compress less than expected, and the multiple holds. All three simultaneously. The article published April 3, 2026 asking what revenue growth rate justifies the valuation posed exactly the right question. The honest answer is that the current price requires a growth rate and margin outcome that is possible but far from guaranteed. The bull case requires believing three things simultaneously, and the probability that all three materialize is lower than the current valuation implies.
This is not an argument that the stock will collapse. It is an argument that the margin of safety is thin and the downside from multiple compression is substantial.